Free Trial

Novartis (NVS) News Today

Novartis logo
$145.11 -0.92 (-0.63%)
Closing price 03:59 PM Eastern
Extended Trading
$145.21 +0.09 (+0.06%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NVS Latest News

Novartis AG $NVS Shares Sold by UBS Group AG
Novartis Q1 Earnings Call Highlights
Novartis: Revenue Lags In Q1, Outlook Unchanged
Novartis misses in Q1 but sticks with full-year outlook
Novartis: Q1 Earnings Snapshot
Novartis Q1 profit down on US generic erosion
WHO prequalifies Novartis’ Coartem Baby for infants
Novartis (NVS) Projected to Post Earnings on Tuesday
Get Novartis News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVS Media Mentions By Week

NVS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NVS
News Sentiment

0.59

0.43

Average
Medical
News Sentiment

NVS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NVS Articles
This Week

21

10

NVS Articles
Average Week

Get the Latest News and Ratings for NVS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Novartis and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NYSE:NVS) was last updated on 5/11/2026 by MarketBeat.com Staff.
From Our Partners